Joseph Glorioso, III, MD, PhD: Turning Bad Guys into Good Guys
Years Funded: 2018-2020
Antigenic Stealthing of oHSV for Systemic Treatment of Melanoma
At the University of Pittsburgh (Pittsburgh, PA), Joseph Glorioso, III, MD, PhD, is pioneering creative new strategies to more safely and successfully target and triumph over melanoma and other metastatic cancers. His studies build on past successes in fighting solid tumors with viruses and a patient’s own immune system.